Medical Policy and Coding Updates - March 2020
Summary
Multiple drug and treatment policies updated with new medications, biosimilar preferences, and prior authorization requirements. Key changes include new biosimilar hierarchies for cancer drugs, updated age criteria for asthma medications, and new prior authorization requirements for multiple sclerosis treatments.
Get alerts when payers change rules like this one
We check Premera Blue Cross and other payers every day and email you when a change matches your specialty and state.